Company Filing History:

7 out of 4,770

Merck + Co., Inc.

patents

Years Active: 1992-1997

Loading Chart...

7 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 5596113 - Ruthenium-phosphine complex catalysts for asymmetric hydrogenations (1997-01-21),

2. 5508435 - Asymmetric hydrogenation of beta- or gamma-ketoesters and beta- or (1996-04-16),

3. 5426230 - Process for the preparation of 4-chloro-2-cyclopropylcarbonylaniline (1995-06-20),

4. 5187278 - Trialkylsilyl trifluoromethanesulfonate mediated .alpha.-methylenic (1993-02-16),

5. 5116983 - Dehydrogenation process intermediates (1992-05-26),

6. 5091534 - Trialkylsilyl trifluoromethanesulfonate mediated .alpha.-methylenic (1992-02-25),

7. 5084574 - Dehydrogenation process (1992-01-28),

Title: The Inventor Alan W Douglas: Pioneering Innovations in Monmouth Junction

Introduction: Alan W Douglas is a distinguished inventor based in Monmouth Junction, NJ, known for his groundbreaking contributions to various fields.

Latest Patents: Alan W Douglas holds several patents in the areas of technology and engineering, showcasing his continuous commitment to innovation.

Career Highlights: With a career spanning over two decades, Alan W Douglas has established himself as a visionary inventor, with a keen eye for identifying gaps in the market and developing unique solutions.

Collaborations: Throughout his career, Alan W Douglas has collaborated with leading companies, research institutions, and universities to bring his inventions to life, fostering a culture of creativity and excellence.

Conclusion: Alan W Douglas's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors, leaving a lasting impact on the world of technology and beyond.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com